{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:11Z","timestamp":1791412031838,"version":"4.3.3"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.bcmd.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T04:59:00Z","timestamp":1239166740000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Circulating endothelial cells: A potential parameter of organ damage in sickle cell anemia?"],"prefix":"10.1016","volume":"43","author":[{"given":"Michiel H.","family":"Strijbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precious P.","family":"Landburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Nur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita W.","family":"Rijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Biemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sleijfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Gratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Duits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-John B.","family":"Schnog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2009.02.007_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.2008.07097.x","article-title":"Advances in clinical research in sickle cell disease","volume":"141","author":"Hagar","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib2","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2002-10-3313","article-title":"Transgenic sickle mice have vascular inflammation","volume":"101","author":"Belcher","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00277-003-0609-1","article-title":"Steady-state sVCAM-1 serum levels in adults with sickle cell disease","volume":"82","author":"Schnog","year":"2003","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib4","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.V97.6.1584","article-title":"Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation","volume":"97","author":"Belhassen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.02.007_bib5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJM199711273372203","article-title":"Circulating activated endothelial cells in sickle cell anemia","volume":"337","author":"Solovey","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","article-title":"Predicting clinical severity in sickle cell anaemia","volume":"129","author":"Steinberg","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2007-07-100719","article-title":"Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort","volume":"111","author":"Quinn","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1538-7836.2008.02918.x","article-title":"Circulating endothelial cells: from bench to clinical practice","volume":"6","author":"Shantsila","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cyto.a.20364","article-title":"Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas","volume":"71","author":"Rowand","year":"2007","journal-title":"Cytometry, A"},{"key":"10.1016\/j.bcmd.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3324\/haematol.12152","article-title":"Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice","volume":"93","author":"van Beers","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2009.02.007_bib11","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.STR.0000244767.39962.f7","article-title":"High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability","volume":"37","author":"Bongers","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2009.02.007_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00277-004-0983-3","article-title":"Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease","volume":"84","author":"Schnog","year":"2005","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"A Wilcoxon-type test for trend","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat. Med."},{"key":"10.1016\/j.bcmd.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.bjc.6604383","article-title":"Circulating endothelial cells in oncology: pitfalls and promises","volume":"98","author":"Strijbos","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcmd.2009.02.007_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jlb.66.3.411","article-title":"Neutrophil activation in sickle cell disease","volume":"66","author":"Lard","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood.V93.11.3824","article-title":"Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells","volume":"93","author":"Solovey","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ajh.20653","article-title":"ADAMTS13 activity in sickle cell disease","volume":"81","author":"Schnog","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/clin.1996.0163","article-title":"Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis","volume":"81","author":"Duits","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.CIR.0000044943.12533.A8","article-title":"Divergent nitric oxide bioavailability in men and women with sickle cell disease","volume":"107","author":"Gladwin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3324\/haematol.12928","article-title":"Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension","volume":"93","author":"Landburg","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2009.02.007_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassemia","volume":"2008","author":"Morris","year":"2008","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979609000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979609000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:25:51Z","timestamp":1761049551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979609000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1079979609000576"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.02.007","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating endothelial cells: A potential parameter of organ damage in sickle cell anemia?","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}